Literature DB >> 26339439

Urothelial carcinoma with oncocytic features: an extremely rare case presenting a diagnostic challenge in urine cytology.

Shogo Tajima1.   

Abstract

Recognizing histological variants in urothelial carcinoma (UC) is important because some may be associated with different clinical outcomes and/or therapeutic approaches; being aware of unusual histological variants may also be crucial in preventing diagnostic misinterpretations. Histological variants based on cytoplasmic features, such as clear-cell, plasmacytoid, rhabdoid, and lipoid-rich variants, are described in invasive UC; however, these cytoplasmic features are not formally defined and not usually encountered in non-invasive UC. Oncocytic cytoplasm has not been well described in either invasive or non-invasive UC. Herein, we report an exceedingly rare case of UC with oncocytic features arising in the right renal pelvis, which presented a diagnostic challenge in urine cytology due to the relatively low nuclear-to-cytoplasmic ratio; however, it could definitively be diagnosed using histological specimens. UC diagnosis is based on the presence of papillary architecture and widespread p53 nuclear accumulation, suggesting malignancy. An oncocytic tumor is generally considered to be not actively dividing, as shown by the low Ki-67 labeling index in this case. In spite of the low proliferative activity, the possibility of intravesicle recurrence (IVR) should be considered since positive preoperative cytology of upper tract UC is a risk factor for IVR after nephroureterectomy.

Entities:  

Keywords:  Urothelial carcinoma; histology; immunohistochemistry; oncocytic features; renal pelvis; urine cytology

Mesh:

Substances:

Year:  2015        PMID: 26339439      PMCID: PMC4555767     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  20 in total

Review 1.  Tissue that has lost its track: Warthin's tumour.

Authors:  A Teymoortash; J A Werner
Journal:  Virchows Arch       Date:  2005-05-24       Impact factor: 4.064

2.  Warthin's tumour.

Authors:  Manuel Sobrinho-Simões; Valdemar Máximo
Journal:  Virchows Arch       Date:  2006-04-12       Impact factor: 4.064

3.  Malignant potential of small oncocytic follicular carcinoma/Hürthle cell carcinoma: an institutional experience.

Authors:  Teresa Danielle Samulski; Shuting Bai; Virginia A LiVolsi; Kathleen Montone; Zubair Baloch
Journal:  Histopathology       Date:  2013-08-19       Impact factor: 5.087

4.  Immunohistochemical evaluation of novel and traditional markers associated with urothelial differentiation in a spectrum of variants of urothelial carcinoma of the urinary bladder.

Authors:  Gladell P Paner; Chandrakanth Annaiah; Christian Gulmann; Priya Rao; Jae Y Ro; Donna E Hansel; Steven S Shen; Antonio Lopez-Beltran; Manju Aron; Daniel J Luthringer; Mariza De Peralta-Venturina; Yong Cho; Mahul B Amin
Journal:  Hum Pathol       Date:  2014-03-14       Impact factor: 3.466

Review 5.  Renal hybrid oncocytic/chromophobe tumors - a review.

Authors:  Ondrej Hes; Fredrik Petersson; Naoto Kuroda; Milan Hora; Michal Michal
Journal:  Histol Histopathol       Date:  2013-06-06       Impact factor: 2.303

6.  Uroplakin II (UPII), GATA3, and p40 are Highly Sensitive Markers for the Differential Diagnosis of Invasive Urothelial Carcinoma.

Authors:  Laura L Hoang; David Tacha; Ryan E Bremer; Thomas S Haas; Liang Cheng
Journal:  Appl Immunohistochem Mol Morphol       Date:  2015 Nov-Dec

7.  Acquired cystic disease-associated renal cell carcinoma: an immunohistochemical and fluorescence in situ hybridization study.

Authors:  Naoto Kuroda; Motoki Yamashita; Yoshiyuki Kakehi; Ondrej Hes; Michal Michal; Gang-Hong Lee
Journal:  Med Mol Morphol       Date:  2011-12-17       Impact factor: 2.309

Review 8.  A Systematic Review and Meta-analysis of Clinicopathologic Factors Linked to Intravesical Recurrence After Radical Nephroureterectomy to Treat Upper Tract Urothelial Carcinoma.

Authors:  Thomas Seisen; Benjamin Granger; Pierre Colin; Priscilla Léon; Guillemette Utard; Raphaële Renard-Penna; Eva Compérat; Pierre Mozer; Olivier Cussenot; Shahrokh F Shariat; Morgan Rouprêt
Journal:  Eur Urol       Date:  2014-12-06       Impact factor: 20.096

9.  FGFR3 and TP53 mutation analysis in inverted urothelial papilloma: incidence and etiological considerations.

Authors:  Sarah Lott; Mingsheng Wang; Shaobo Zhang; Gregory T MacLennan; Antonio Lopez-Beltran; Rodolfo Montironi; Ming-Tse Sung; Puay-Hoon Tan; Liang Cheng
Journal:  Mod Pathol       Date:  2009-03-13       Impact factor: 7.842

Review 10.  Histological variants of urothelial carcinoma: diagnostic, therapeutic and prognostic implications.

Authors:  Mahul B Amin
Journal:  Mod Pathol       Date:  2009-06       Impact factor: 7.842

View more
  1 in total

Review 1.  Unusual Faces of Bladder Cancer.

Authors:  Claudia Manini; José I López
Journal:  Cancers (Basel)       Date:  2020-12-10       Impact factor: 6.639

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.